Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Clinical Study of Molecular Subtyping Combined With MRD-driven Remission Induction Regimen in Children and Adolescents With AML: A Phase II Cohort Study (GMCAII)

NCT06221683 is registered in ClinicalTrials.gov with Children's Hospital of Soochow University as lead sponsor.

NCT NCT06221683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06221683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Clinical Study of Molecular Subtyping Combined With MRD-driven Remission Induction Regimen in Children and Adolescents With AML: A Phase II Cohort Study (GMCAII)
Lead sponsor
Children's Hospital of Soochow University
Phase
Phase 2
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2029
Enrollment
500 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, aml, childhood